Psychiatry and Neurology, Neurology · Atlanta, GA
NPI
1326022583
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
6
Medicare group memberships
Hospitals
6
Hospital affiliations
285 Boulevard NE Ste 610
Atlanta, GA, 30312
Phone (404) 653-0039
Groups this clinician bills Medicare through
Medicare paid, 2024
$369K
26,299 services
Medicare patients, 2024
653
Average age 72
Drug cost, 2024
$2.3M
5,315 prescriptions
Company payments, 2025
$4,301
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Husham P Mishu was code J0585 (injection, onabotulinumtoxina, 1 unit), 19,800 times for 26 patients. In total Husham P Mishu billed 26,299 services in 56 codes, and Medicare paid $369K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 19,800 | 26 | $4.60 | $91K |
| G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 3,039 | 279 | $24.82 | $75K |
| 99215 Office E&M - Established | Office | 427 | 236 | $123.84 | $53K |
| 92548 Test - Miscellaneous | Office | 404 | 246 | $34.80 | $14K |
| 97140 PT Treatment | Office | 398 | 29 | $15.75 | $6,270 |
| 95938 Electrical Nerve Conductivity | Facility | 334 | 321 | $34.97 | $12K |
| 95861 Electrical Nerve Conductivity | Facility | 259 | 248 | $62.57 | $16K |
| 97112 PT Treatment | Office | 180 | 21 | $19.83 | $3,569 |
| 95937 Electrical Nerve Conductivity | Facility | 172 | 168 | $26.54 | $4,565 |
| 95939 Electrical Nerve Conductivity | Facility | 169 | 165 | $91.17 | $15K |
| 97110 PT Treatment | Office | 161 | 23 | $19.39 | $3,121 |
| 97530 PT Treatment | Office | 115 | 14 | $27.20 | $3,127 |
| 95874 Musculoskeletal | Office | 83 | 28 | $56.48 | $4,688 |
| 95870 Electrical Nerve Conductivity | Facility | 74 | 37 | $15.31 | $1,133 |
| 99205 Office E&M - New | Office | 60 | 60 | $161.96 | $9,717 |
By year: 2022 $564K for 37,110 services; 2023 $546K for 35,447 services; 2024 $369K for 26,299 services.
Medicare prescription drug claims, 2024
In 2024, the drug Husham P Mishu prescribed most often to Medicare patients was Memantine Hcl, with 389 prescriptions and refills. In total Husham P Mishu wrote 5,315 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 389 | 893 | 116 | $11K |
| Clonazepam Generic | 311 | 422 | 59 | $3,109 |
| Donepezil Hcl Generic | 224 | 557 | 65 | $2,653 |
| Gabapentin Generic | 183 | 329 | 53 | $3,772 |
| Duloxetine Hcl Generic | 155 | 341 | 44 | $7,693 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 126 | 126 | 24 | $2,654 |
| Ziprasidone Hcl Generic | 103 | 143 | 19 | $6,096 |
| Lamotrigine Generic | 102 | 186 | 23 | $1,612 |
| Botox Onabotulinumtoxina | 91 | 257 | 31 | $180K |
| Cyclobenzaprine Hcl Generic | 90 | 142 | 21 | $1,054 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 84 | 84 | 13 | $2,749 |
| Tizanidine Hcl Generic | 77 | 185 | 23 | $1,529 |
| Primidone Generic | 75 | 170 | 21 | $1,418 |
| Qulipta Atogepant | 70 | 84 | 12 | $91K |
| Nortriptyline Hcl Generic | 68 | 121 | 25 | $1,543 |
Brand drugs: - claims; generic drugs: 4,394 claims; opioid claims: 600.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Husham P Mishu $4,301 ($4,301 in general payments such as food, travel and fees) from 42 companies. The largest payer was Abbvie Inc. with $551.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $551 |
| Axsome Therapeutics, Inc. AXSM | 15 | $373 |
| UCB, Inc. UCB.BR | 11 | $326 |
| Biogen, Inc. BIIB | 12 | $275 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $176 |
| Lundbeck LLC | 6 | $169 |
| Harmony Biosciences LLC HRMY | 6 | $165 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $152 |
| Pfizer Inc. PFE | 6 | $148 |
| Catalyst Pharmaceuticals, Inc. CPRX | 5 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.